➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Harvard Business School
Express Scripts
McKesson
Merck

Last Updated: May 16, 2021

DrugPatentWatch Database Preview

PTAB Cases for Patent Owner: Novartis AG

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Patent Trial and Appeal Board Cases for Patent Owner: Novartis AG

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
5,665,772 BRECKENRIDGE PHARMACEUTICAL, INC.   Get Started for $10 2016-05-10 05-10-2016 Novartis AG Inter partes review   Get Started for $10 SYLVAIN COTTENS   Get Started for $10
5,665,772 Par Pharmaceutical, Inc.   Get Started for $10 2016-05-17 05-17-2016 Novartis AG Inter partes review   Get Started for $10 10-27-2016 SYLVAIN COTTENS   Get Started for $10
5,665,772 Roxane Laboratories, Inc.   Get Started for $10 2016-05-26 05-26-2016 Novartis AG Inter partes review   Get Started for $10 SYLVAIN COTTENS   Get Started for $10
5,665,772 Breckenridge Pharmaceutical, Inc.   Get Started for $10 2016-05-26 05-26-2016 Novartis AG Inter partes review   Get Started for $10 10-27-2016 SYLVAIN COTTENS   Get Started for $10
6,316,023 Noven Pharmaceuticals, Inc.   Get Started for $10 2014-04-02 04-02-2014 Novartis AG Inter partes review   Get Started for $10 10-14-2014 Bodo Asmussen   Get Started for $10
6,316,023 Mylan Pharmaceuticals Inc.   Get Started for $10 2014-11-13 11-13-2014 Novartis AG Inter partes review   Get Started for $10 04-10-2015 Bodo Asmussen   Get Started for $10
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
McKesson
Johnson and Johnson
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.